<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
ANG Lifesciences India Ltd has informed BSE that it does not fall under the 'Large Corporate' category as defined under SEBI's circular dated November 26, 2018, as on March 31, 2025. The SEBI circular requires large corporates (those meeting certain borrowing thresholds) to make annual disclosures regarding their fund-raising plans through debt securities. Since the company is not classified as a large corporate, this disclosure requirement does not apply to it. The intimation was signed by the Managing Director (DIN: 01423407) on April 24, 2025.
This is a routine regulatory filing with no material impact on shareholders or the stock price. It simply confirms that the company's borrowing levels are below the SEBI threshold for large corporate classification, meaning it has no mandatory debt-raising disclosure obligations under this framework.